Coulie Bernard
SEC CIK 1808895 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PLRX | PLIANT THERAPEUTICS, INC. | Pres, CEO, Dir | 505.6K | — | $12.80M | 32 | 2022-07-11 | 2026-01-20 |
Most active insiders at PLRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Coulie Bernard | Pres, CEO, Dir | — | $114.4K |
| 2 | Cummings Keith Lamont | CFO | — | $30.7K |
| 3 | Cheung Lily | Chief Human Resource Off | — | $9,644 |
| 4 | Kuo Minnie | COO | — | $8,854 |
Transactions 32
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-22 | 2026-01-20 | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | S - Sale | $1.28 | -89.4K | 505.6K | -15% | -$114.4K | |
| D | 2025-01-27 | 2025-01-23 | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | A - Grant | $0.00 | +162.5K | 593.0K | +38% | $0 |
| 2025-01-22 | 2025-01-17 | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | S - Sale | $11.20 | -52.4K | 430.5K | -11% | -$587.1K | |
| 2024-07-12 | 2024-07-10 | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | S - Sale | $11.56 | -38.7K | 482.9K | -7% | -$447.5K | |
| 2024-07-11 | 2024-07-09 | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | A - Grant | $0.00 | +75.6K | 521.6K | +17% | $0 | |
| D | 2024-01-24 | 2024-01-23 | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | A - Grant | $0.00 | +128.2K | 444.5K | +41% | $0 |
| 2024-01-19 | 2024-01-17 | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | S - Sale | $17.23 | -25.7K | 316.4K | -8% | -$443.2K | |
| 2023-07-19 | 2023-07-17 | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | S - Sale | $18.01 | -70.2K | 342.1K | -17% | -$1.26M | |
| 2023-07-18 | 2023-07-14 | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | A - Grant | $0.00 | +137.5K | 412.3K | +50% | $0 | |
| 2023-04-03 | 2023-03-30 | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | S - Sale | $26.52 | -35.3K | 274.8K | -11% | -$937.2K | |
| 2023-03-31 | 2023-03-29 | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | A - Grant | $0.00 | +68.7K | 310.1K | +28% | $0 | |
| DM | 2023-02-06 | 2023-02-02+ | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $33.92 | -30.0K | 245.4K | -11% | -$1.02M |
| DM | 2023-02-06 | 2023-02-02+ | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | M - OptEx | $6.22 | +30.0K | 255.1K | +13% | +$186.6K |
| DM | 2023-02-01 | 2023-01-30+ | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | M - OptEx | $3.87 | +45.0K | 255.1K | +21% | +$174.2K |
| DM | 2023-02-01 | 2023-01-30+ | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $34.48 | -45.0K | 243.7K | -16% | -$1.55M |
| DM | 2023-01-27 | 2023-01-26+ | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | M - OptEx | $2.08 | +30.0K | 255.1K | +13% | +$62.4K |
| DM | 2023-01-27 | 2023-01-26+ | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $35.49 | -30.0K | 240.1K | -11% | -$1.06M |
| DMI | 2023-01-27 | 2023-01-26+ | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $35.11 | -25.0K | 409.5K | -6% | -$877.7K |
| D | 2023-01-27 | 2023-01-25 | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | A - Grant | $0.00 | +146.3K | 240.1K | +156% | $0 |
| DM | 2023-01-25 | 2023-01-23+ | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | M - OptEx | $2.08 | +45.0K | 108.8K | +71% | +$93.6K |
| DM | 2023-01-25 | 2023-01-23+ | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $32.50 | -45.0K | 98.7K | -31% | -$1.46M |
| DI | 2023-01-25 | 2023-01-23 | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $35.00 | -15.0K | 434.3K | -3% | -$525.0K |
| DM | 2023-01-09 | 2023-01-06+ | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | M - OptEx | $2.08 | +20.0K | 108.8K | +23% | +$41.6K |
| DM | 2023-01-09 | 2023-01-06+ | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $19.07 | -20.0K | 93.8K | -18% | -$381.5K |
| DM | 2023-01-05 | 2023-01-03+ | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | M - OptEx | $2.08 | +30.0K | 108.8K | +38% | +$62.4K |
| DM | 2023-01-05 | 2023-01-03+ | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $19.20 | -30.0K | 93.8K | -24% | -$575.9K |
| 2022-12-21 | 2022-12-20 | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | S - Sale | $19.10 | -34.2K | 93.8K | -27% | -$653.4K | |
| 2022-12-21 | 2022-12-19 | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | A - Grant | $0.00 | +68.8K | 128.0K | +116% | $0 | |
| D | 2022-09-14 | 2022-09-12 | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $22.54 | -12.5K | 59.3K | -17% | -$281.8K |
| D | 2022-09-14 | 2022-09-12 | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | M - OptEx | $2.08 | +12.5K | 71.8K | +21% | +$26.0K |
| DM | 2022-07-13 | 2022-07-11+ | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $22.50 | -27.5K | 59.3K | -32% | -$618.7K |
| DM | 2022-07-13 | 2022-07-11+ | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Pres, CEO, Dir | M - OptEx | $2.08 | +27.5K | 74.3K | +59% | +$57.2K |
Purchase Sale Sale after option exercise All abbreviations